QUYNH LUONG: Open Payments
NPI 1962126086 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$715 in 29 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $227 · 2025 $715
Food & beverage: $715
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 14 | $269 |
| E.R. Squibb & Sons, L.L.C. | 3 | $162 |
| Boston Scientific Corporation | 5 | $146 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
| Novartis Pharmaceuticals Corporation | 2 | $30 |
| Alnylam Pharmaceuticals Inc. | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
Products named: REPATHA, CDS broad portfolio offering, Kerendia, LEQVIO, ONPATTRO, VERQUVO, ELIQUIS, JARDIANCE.
Industry payments across OK — which companies pay providers there.
